Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$314.38
0.000.00%
Pre-Market: 4:28 PM EDT
Comments
Loading...
Amgen Analyst Ratings and Price Targets | NASDAQ:AMGN | Benzinga
Amgen Inc has a consensus price target of $313.59 based on the ratings of 32 analysts. The high is $405 issued by Cantor Fitzgerald on October 22, 2024. The low is $200 issued by Credit Suisse on July 12, 2023. The 3 most-recent analyst ratings were released by B of A Securities, Piper Sandler, and B of A Securities on March 5, 2025, February 10, 2025, and February 6, 2025, respectively. With an average price target of $299.33 between B of A Securities, Piper Sandler, and B of A Securities, there's an implied -4.79% downside for Amgen Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Piper Sandler
Citigroup
RBC Capital
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Amgen
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/05/2025 | Buy Now | -6.48% | B of A Securities | Tim Anderson53% | $275 → $294 | Maintains | Underperform | Get Alert |
| 02/10/2025 | Buy Now | 4.65% | Piper Sandler | David Amsellem69% | $310 → $329 | Maintains | Overweight | Get Alert |
| 02/06/2025 | Buy Now | -12.53% | B of A Securities | Tim Anderson53% | $256 → $275 | Maintains | Underperform | Get Alert |
| 01/28/2025 | Buy Now | -6.16% | Citigroup | Geoff Meacham63% | $310 → $295 | Maintains | Neutral | Get Alert |
| 01/24/2025 | Buy Now | 3.06% | RBC Capital | Gregory Renza49% | $324 → $324 | Reiterates | Outperform → Outperform | Get Alert |
| 01/10/2025 | Buy Now | -10.94% | Wells Fargo | Mohit Bansal73% | $335 → $280 | Maintains | Equal-Weight | Get Alert |
| 01/08/2025 | Buy Now | -5.21% | Truist Securities | Robyn Karnauskas56% | $333 → $298 | Maintains | Hold | Get Alert |
| 01/02/2025 | Buy Now | -1.39% | Piper Sandler | David Amsellem69% | $344 → $310 | Maintains | Overweight | Get Alert |
| 12/10/2024 | Buy Now | -18.57% | B of A Securities | Tim Anderson53% | → $256 | Reinstates | → Underperform | Get Alert |
| 11/27/2024 | Buy Now | 4.97% | RBC Capital | Gregory Renza49% | $360 → $330 | Maintains | Outperform | Get Alert |
| 11/15/2024 | Buy Now | — | Wolfe Research | Tim Anderson53% | — | Initiates | → Peer Perform | Get Alert |
| 11/14/2024 | Buy Now | 6.56% | Citigroup | Geoff Meacham63% | → $335 | Initiates | → Neutral | Get Alert |
| 11/12/2024 | Buy Now | 20.87% | Jefferies | Michael Yee56% | $380 → $380 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | 3.7% | UBS | Colin Bristow41% | $335 → $326 | Maintains | Neutral | Get Alert |
| 10/22/2024 | Buy Now | 28.82% | Cantor Fitzgerald | Olivia Brayer62% | $405 → $405 | Reiterates | Overweight → Overweight | Get Alert |
| 10/21/2024 | Buy Now | 21.83% | TD Cowen | Yaron Weber41% | $381 → $383 | Maintains | Buy | Get Alert |
| 10/17/2024 | Buy Now | 20.87% | Bernstein | Aaron Gal54% | → $380 | Initiates | → Outperform | Get Alert |
| 10/14/2024 | Buy Now | 5.92% | Truist Securities | Robyn Karnauskas56% | $320 → $333 | Downgrade | Buy → Hold | Get Alert |
| 10/07/2024 | Buy Now | 0.2% | Barclays | Carter Gould58% | $300 → $315 | Maintains | Equal-Weight | Get Alert |
| 09/27/2024 | Buy Now | 28.82% | Cantor Fitzgerald | Olivia Brayer62% | → $405 | Initiates | → Overweight | Get Alert |
| 09/26/2024 | Buy Now | 15.15% | RBC Capital | Gregory Renza49% | $362 → $362 | Reiterates | Outperform → Outperform | Get Alert |
| 09/25/2024 | Buy Now | -31.61% | Baird | Brian Skorney58% | $215 → $215 | Reiterates | Underperform → Underperform | Get Alert |
| 08/07/2024 | Buy Now | 21.19% | TD Cowen | Yaron Weber41% | $360 → $381 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 20.87% | Oppenheimer | Jay Olson62% | $380 → $380 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | -2.98% | Deutsche Bank | James Shin42% | $310 → $305 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2024 | Buy Now | 4.97% | B of A Securities | Geoff Meacham63% | $325 → $330 | Maintains | Neutral | Get Alert |
| 08/07/2024 | Buy Now | 15.15% | RBC Capital | Gregory Renza49% | $332 → $362 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | 6.56% | Wells Fargo | Mohit Bansal73% | $320 → $335 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/11/2024 | Buy Now | -3.62% | Morgan Stanley | Terence Flynn66% | $310 → $303 | Maintains | Equal-Weight | Get Alert |
| 06/27/2024 | Buy Now | 8.15% | Argus Research | David Toung72% | $300 → $340 | Maintains | Buy | Get Alert |
| 06/14/2024 | Buy Now | 5.6% | RBC Capital | Gregory Renza49% | $328 → $332 | Maintains | Outperform | Get Alert |
| 05/09/2024 | Buy Now | -25.25% | Mizuho | Salim Syed44% | $223 → $235 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 4.33% | RBC Capital | Gregory Renza49% | $332 → $328 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | -1.39% | Morgan Stanley | Terence Flynn66% | $271 → $310 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | -2.35% | UBS | Colin Bristow41% | $284 → $307 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | — | William Blair | Matthew Phipps23% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 05/03/2024 | Buy Now | 12.92% | BMO Capital | Evan David Seigerman56% | $336 → $355 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | -4.57% | Barclays | Carter Gould58% | $230 → $300 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/17/2024 | Buy Now | -9.66% | UBS | Colin Bristow41% | $314 → $284 | Maintains | Neutral | Get Alert |
| 04/17/2024 | Buy Now | 14.51% | TD Cowen | Yaron Weber41% | $370 → $360 | Maintains | Buy | Get Alert |
| 04/12/2024 | Buy Now | 1.79% | Truist Securities | Robyn Karnauskas56% | $320 → $320 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | Buy Now | 4.65% | RBC Capital | Gregory Renza49% | $329 → $329 | Reiterates | Outperform → Outperform | Get Alert |
| 03/28/2024 | Buy Now | — | Raymond James | Gary Nachman58% | — | Reinstates | → Market Perform | Get Alert |
| 02/08/2024 | Buy Now | 11.33% | Goldman Sachs | Salveen Richter52% | $313 → $350 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | -11.57% | Morgan Stanley | Terence Flynn66% | $281 → $278 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | Buy Now | 4.65% | RBC Capital | Gregory Renza49% | $303 → $329 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | 11.33% | Goldman Sachs | Salveen Richter52% | $313 → $350 | Maintains | Buy | Get Alert |
| 02/01/2024 | Buy Now | 11.33% | Oppenheimer | Jay Olson62% | → $350 | Reiterates | Outperform → Outperform | Get Alert |
| 01/29/2024 | Buy Now | -0.12% | UBS | Colin Bristow41% | $315 → $314 | Maintains | Neutral | Get Alert |
| 12/21/2023 | Buy Now | 1.79% | Daiwa Capital | Narumi Nakagiri23% | → $320 | Upgrade | Neutral → Buy | Get Alert |
| 12/19/2023 | Buy Now | 3.7% | BMO Capital | Evan David Seigerman56% | $286 → $326 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/12/2023 | Buy Now | -4.57% | RBC Capital | Gregory Renza49% | $256 → $300 | Upgrade | Sector Perform → Outperform | Get Alert |
| 11/29/2023 | Buy Now | 1.79% | Truist Securities | Robyn Karnauskas56% | → $320 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | Buy Now | -23.66% | Deutsche Bank | James Shin42% | → $240 | Initiates | → Hold | Get Alert |
| 11/02/2023 | Buy Now | -18.57% | RBC Capital | Gregory Renza49% | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 11/02/2023 | Buy Now | 1.79% | Truist Securities | Robyn Karnauskas56% | → $320 | Upgrade | Hold → Buy | Get Alert |
| 11/02/2023 | Buy Now | -14.75% | UBS | Colin Bristow41% | $272 → $268 | Maintains | Neutral | Get Alert |
| 11/01/2023 | Buy Now | -18.57% | RBC Capital | Gregory Renza49% | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 11/01/2023 | Buy Now | -7.44% | Morgan Stanley | Terence Flynn66% | $300 → $291 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | Buy Now | -1.39% | Oppenheimer | Jay Olson62% | $300 → $310 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | -4.57% | Oppenheimer | Jay Olson62% | $290 → $300 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | -14.12% | JP Morgan | Chris Schott61% | → $270 | Reinstates | Neutral → Neutral | Get Alert |
| 10/17/2023 | Buy Now | -1.39% | Argus Research | David Toung72% | $280 → $310 | Maintains | Buy | Get Alert |
| 10/17/2023 | Buy Now | -4.57% | Morgan Stanley | Terence Flynn66% | → $300 | Reinstates | → Equal-Weight | Get Alert |
| 10/12/2023 | Buy Now | -1.39% | Jefferies | Michael Yee56% | $310 → $310 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2023 | Buy Now | 1.15% | Leerink Partners | David Risinger74% | $267 → $318 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/11/2023 | Buy Now | -7.75% | B of A Securities | Geoff Meacham63% | → $290 | Reinstates | → Neutral | Get Alert |
| 10/09/2023 | Buy Now | -7.75% | Oppenheimer | Jay Olson62% | $280 → $290 | Maintains | Outperform | Get Alert |
| 09/18/2023 | Buy Now | -10.94% | Argus Research | David Toung72% | $260 → $280 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | 1.79% | HSBC | Morten Herholdt40% | → $320 | Initiates | → Buy | Get Alert |
| 09/05/2023 | Buy Now | -17.3% | Truist Securities | Robyn Karnauskas56% | → $260 | Reiterates | Hold → Hold | Get Alert |
| 08/14/2023 | Buy Now | -1.39% | Jefferies | Michael Yee56% | $275 → $310 | Maintains | Buy | Get Alert |
| 08/14/2023 | Buy Now | -29.07% | Mizuho | Salim Syed44% | $214 → $223 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | -19.52% | RBC Capital | Gregory Renza49% | $250 → $253 | Maintains | Sector Perform | Get Alert |
| 07/25/2023 | Buy Now | -10.94% | Oppenheimer | Jay Olson62% | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 07/12/2023 | Buy Now | -36.38% | Credit Suisse | Trung Huynh69% | $220 → $200 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | -33.2% | Barclays | Carter Gould58% | $225 → $210 | Maintains | Underweight | Get Alert |
| 06/26/2023 | Buy Now | -17.3% | Argus Research | David Toung72% | $270 → $260 | Maintains | Buy | Get Alert |
| 05/18/2023 | Buy Now | -10.94% | Oppenheimer | Jay Olson62% | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2023 | Buy Now | -19.21% | RBC Capital | Gregory Renza49% | → $254 | Reiterates | → Sector Perform | Get Alert |
| 05/01/2023 | Buy Now | -28.43% | Barclays | Carter Gould58% | $227 → $225 | Maintains | Underweight | Get Alert |
| 04/28/2023 | Buy Now | -8.39% | Piper Sandler | Christopher Raymond57% | $293 → $288 | Maintains | Overweight | Get Alert |
| 04/24/2023 | Buy Now | -7.75% | Oppenheimer | Jay Olson62% | $292 → $290 | Maintains | Outperform | Get Alert |
| 04/14/2023 | Buy Now | -27.79% | Barclays | Carter Gould58% | $230 → $227 | Maintains | Underweight | Get Alert |
| 03/13/2023 | Buy Now | -15.71% | Wells Fargo | Mohit Bansal73% | $275 → $265 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/13/2023 | Buy Now | -17.3% | Truist Securities | Robyn Karnauskas56% | $280 → $260 | Maintains | Hold | Get Alert |
| 02/02/2023 | Buy Now | -15.07% | SVB Leerink | David Risinger74% | $282 → $267 | Maintains | Market Perform | Get Alert |
| 02/01/2023 | Buy Now | -12.53% | Wells Fargo | Mohit Bansal73% | $285 → $275 | Maintains | Equal-Weight | Get Alert |
| 02/01/2023 | Buy Now | -17.93% | RBC Capital | Gregory Renza49% | $268 → $258 | Maintains | Sector Perform | Get Alert |
| 02/01/2023 | Buy Now | -6.48% | Oppenheimer | Jay Olson62% | $312 → $294 | Maintains | Outperform | Get Alert |
| 02/01/2023 | Buy Now | -8.07% | Cowen & Co. | Yaron Weber41% | $307 → $289 | Maintains | Outperform | Get Alert |
| 02/01/2023 | Buy Now | -30.02% | Credit Suisse | Trung Huynh69% | $240 → $220 | Maintains | Underperform | Get Alert |
| 02/01/2023 | Buy Now | -19.52% | BMO Capital | Evan David Seigerman56% | $276 → $253 | Maintains | Market Perform | Get Alert |
| 02/01/2023 | Buy Now | -26.84% | Barclays | Carter Gould58% | $240 → $230 | Maintains | Underweight | Get Alert |
| 01/19/2023 | Buy Now | -6.8% | Piper Sandler | Christopher Raymond57% | $299 → $293 | Maintains | Overweight | Get Alert |
| 01/18/2023 | Buy Now | -23.66% | Barclays | Carter Gould58% | $234 → $240 | Maintains | Underweight | Get Alert |
| 01/03/2023 | Buy Now | -9.35% | Wells Fargo | Mohit Bansal73% | $250 → $285 | Maintains | Equal-Weight | Get Alert |
| 12/22/2022 | Buy Now | -10.3% | SVB Leerink | David Risinger74% | $256 → $282 | Maintains | Market Perform | Get Alert |
| 12/13/2022 | Buy Now | -4.89% | Piper Sandler | Christopher Raymond57% | $297 → $299 | Maintains | Overweight | Get Alert |
| 12/06/2022 | Buy Now | -1.39% | Oppenheimer | Jay Olson62% | $300 → $310 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Amgen (AMGN) stock?
The latest price target for Amgen (NASDAQ:AMGN) was reported by B of A Securities on March 5, 2025. The analyst firm set a price target for $294.00 expecting AMGN to fall to within 12 months (a possible -6.48% downside). 43 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Amgen (AMGN)?
The latest analyst rating for Amgen (NASDAQ:AMGN) was provided by B of A Securities, and Amgen maintained their underperform rating.
When was the last upgrade for Amgen (AMGN)?
The last upgrade for Amgen Inc happened on May 3, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Amgen Inc.
When was the last downgrade for Amgen (AMGN)?
The last downgrade for Amgen Inc happened on October 14, 2024 when Truist Securities changed their price target from $320 to $333 for Amgen Inc.
When is the next analyst rating going to be posted or updated for Amgen (AMGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amgen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amgen was filed on March 5, 2025 so you should expect the next rating to be made available sometime around March 5, 2026.
Is the Analyst Rating Amgen (AMGN) correct?
While ratings are subjective and will change, the latest Amgen (AMGN) rating was a maintained with a price target of $275.00 to $294.00. The current price Amgen (AMGN) is trading at is $314.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.